Related Experiment Video
Updated: Jul 2, 2026
05:39
A Fine Motor Task to Study Joint Kinematics in a Preclinical Model of Neurodegenerative Disease
Published on: June 13, 2025
Driving and neurodegenerative diseases.
1Department of Neurology, University of Iowa, Carver College of Medicine, 200 Hawkins Drive-2RCP, Iowa City, IA 52242, USA. ergun-uc@uiowa.edu
Current Neurology and Neuroscience Reports
|August 21, 2008
Summary
As the elderly population grows, neurodegenerative diseases like Alzheimer's and Parkinson's increasingly affect driving safety. Research aims to develop reliable tests to predict crash risk and guide interventions for these drivers.
Area of Science:
- Gerontology
- Neurology
- Transportation Safety
Background:
- The global population is aging, leading to a rise in elderly drivers.
- Neurodegenerative disorders (e.g., Alzheimer's, Parkinson's) significantly impair driving abilities.
- Current methods (age, diagnosis) are insufficient for predicting driver safety in this demographic.
Purpose of the Study:
- To address the challenges in assessing driving fitness in individuals with neurodegenerative disorders.
- To improve the prediction of driver safety and crash risk.
- To inform healthcare providers, policy, and rehabilitation strategies.
Main Methods:
- Utilizing questionnaires on driving habits and history.
- Employing driving simulators for controlled assessments.
- Conducting standardized road tests with instrumented vehicles.
- Analyzing state driving records.
Main Results:
- Neurodegenerative disorders impair cognition, visual perception, and motor function, impacting driving.
- Existing diagnostic and age-based criteria are inadequate for predicting driver safety.
- Challenges remain in tracking the evolution of driving safety and understanding impairment mechanisms.
Conclusions:
- Reliable and efficient assessment tools are needed for drivers with neurodegenerative conditions.
- Improved assessments will enable better patient advice, policy development, and rehabilitative measures.
- This research is crucial for maintaining mobility and safety in an aging population.
Related Concept Videos
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...